De novouse of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring-Reference-Cited by-同舟云学术

De novouse of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring

Published:2015-07-14 Issue:11 Volume:28 Page:1283-1290
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Melilli Edoardo¹,Crespo Elena²,Sandoval Diego¹,Manonelles Anna¹²,Sala Neus¹,Mast Richard³,Padulles Ariadna⁴,Grinyo Josep M.¹,Bestard Oriol¹²,Cruzado Josep Maria¹²

Affiliation:

1. Bellvitge University Hospital; Department of Nephrology; Renal Transplantation Unit carrer de la feixa llarga L'Hospitalet de Llobregat; Barcelona Spain

2. IDIBELL; Department of Experimental Nephrology; Carrer de la feixa llarga L'Hospitalet de Llobregat; Barcelona Spain

3. Department of Radiology; Bellvitge University Hospital; Carrer de la feixa llarga L'Hospitalet de Llobregat; Barcelona Spain

4. Department of Pharmacy; Bellvitge University Hospital; Carrer de la feixa llarga L'Hospitalet de Llobregat; Barcelona Spain

Funder

Spanish Government

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12626/fullpdf

Reference25 articles.

1. Immunosuppression, generic drugs and the FDA;Klintmalm;Am J Transplant,2011

2. Response to Klintmalm on the use of generic immunosuppression;Latran;Am J Transplant,2012

3. Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation;Johnston;Eur J Hosp Pharm,2013

4. The ongoing regulation of generic drugs;Frank;N Engl J Med,2007

5. US Department of Health and Human Services FDA CDER Guidance for Industry. Bioavailability and Bioequivalence. Studies for Orally Administered Drug Products - General Considerations 2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Providing “Free” Access to Dialysis and Transplant to the Disfranchised. A Sustainable Model for Low and Low Middle Income Countries (LMICs);Transplant International;2023-07-11

2. Seeking Standardized Definitions for HLA-incompatible Kidney Transplants: A Systematic Review;Transplantation;2022-08-02

3. Outcomes of De Novo Use of Generic Tacrolimus (Adoport®) in Living-Related Kidney Transplantation: A Single-Center, Real-Life Experience of 5 Years;Turkish Journal of Nephrology;2021-10-15

4. Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients;Transplantation Reports;2020-09

5. Immunosuppression with generic tacrolimus in liver and kidney transplantation—systematic review and meta‐analysis on biopsy‐proven acute rejection and bioequivalence;Transplant International;2020-02-12